An open-label prospective study to investigate the safety, efficacy and tolerability of quetiapine in adolescents and adults experiencing their first psychotic episode in and Australian Health Care Setting.
Study identifier:AU-SEA-0005
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An open-label prospective study to investigate the safety, efficacy and tolerability of quetiapine in adolescents and adults experiencing their first psychotic episode in and Australian Health Care Setting.
Medical condition
schizophrenia
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Aug 2003
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
